These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3322724)

  • 1. Modification of therapy from insulin to chlorpropamide decreases HDL cholesterol in patients with non-insulin-dependent diabetes mellitus.
    Schmitt JK; Harriman K; Poole JR
    Diabetes Care; 1987; 10(6):692-6. PubMed ID: 3322724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High density lipoprotein cholesterol and apolipoprotein a-1 concentrations in non-insulin dependent diabetics treated by diet and chlorpropamide.
    Billingham MS; Leatherdale BA; Hall RA; Bailey CJ
    Diabete Metab; 1982 Sep; 8(3):229-33. PubMed ID: 6814965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorpropamide lowers serum and lipoprotein cholesterol in insulin-dependent diabetes.
    Seviour PW; Teal TK; Richmond W; Elkeles RS
    Diabet Med; 1986 Mar; 3(2):152-4. PubMed ID: 2951157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of serum lipids with diabetes control in sulfonylurea-treated diabetic patients.
    Huupponen RK; Viikari JS; Saarimaa H
    Diabetes Care; 1984; 7(6):575-8. PubMed ID: 6439532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
    Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
    Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.
    Bavirti S; Ghanaat F; Tayek JA
    Endocr Pract; 2003; 9(6):487-93. PubMed ID: 14715475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
    al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
    Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lovastatin in diabetic patients treated with chlorpropamide.
    Johnson BF; LaBelle P; Wilson J; Allan J; Zupkis RV; Ronca PD
    Clin Pharmacol Ther; 1990 Oct; 48(4):467-72. PubMed ID: 2225707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?
    Alagözlü H; Gültekin F; Candan F
    Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal.
    Paisey R; Elkeles RS; Hambley J; Magill P
    Diabetologia; 1978 Aug; 15(2):81-5. PubMed ID: 700275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients.
    Rivellese AA; Patti L; Romano G; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4188-92. PubMed ID: 11095452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels.
    Wolffenbuttel BH; Leurs PB; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
    Diabet Med; 1993 Jun; 10(5):427-30. PubMed ID: 8334821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein abnormalities in well-treated type II diabetic patients.
    Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
    Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?
    Romano G; Patti L; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G; Rivellese AA
    Diabetes; 1997 Oct; 46(10):1601-6. PubMed ID: 9313756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification.
    Sánchez-Quesada JL; Pérez A; Caixàs A; Rigla M; Payés A; Benítez S; Ordóñez-Llanos J
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3243-9. PubMed ID: 11443196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of insulin on cholesterol synthesis in type II diabetes patients.
    Scoppola A; Testa G; Frontoni S; Maddaloni E; Gambardella S; Menzinger G; Lala A
    Diabetes Care; 1995 Oct; 18(10):1362-9. PubMed ID: 8721938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
    Cusi K; Cunningham GR; Comstock JP
    Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transport of vitamin E in plasma and its correlation to plasma lipoproteins in non-insulin-dependent diabetes mellitus.
    Kökoğlu E; Ulakoğlu E
    Diabetes Res Clin Pract; 1991 Dec; 14(3):175-81. PubMed ID: 1778110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.
    Petitti DB; Imperatore G; Palla SL; Daniels SR; Dolan LM; Kershnar AK; Marcovina S; Pettitt DJ; Pihoker C;
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):159-65. PubMed ID: 17283301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
    Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.